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Summary: The kinetics of the degradation of the inhibitors of the nitric oxide synthesis, A/°-nitro-L-arginine methyl
ester and A^-nitro-Zx-arginine, were examined in human amniotic fluid and umbilical vein blood. The reaction rate
constants were calculated or estimated using the time-controlled concentration course of both substances. These
concentrations were measured by high-performance liquid chromatography with two different separation systems:
ion-exchange chromatography and ion-pair chromatography. Using this method, either A/°-nitro-L-arginine methyl
ester and/or M^nitro-L-arginine were added to 18 samples of amniotic fluid, 33 samples of plasma and 21 samples
of uncentrifuged umbilical vein blood samples; subsequently these samples were used for measurement. The degra-
dation of the two individual study substances can be described by a uni-unimolecular two-step consecutive reaction.
Thereby, M'-nitro-L-arginine methyl ester decomposes to A/°-nitro-L-arginine. Although 7V°-nitro-£-arginine decom-
posed further, the decomposition product could not be identified. The average of the reaction rate constants for
A/°-nitro-L-arginine methyl ester/7VG-nitro-L-arginine was determined, yielding the following values: 0.032 h~V
0.00047h-1 in amniotic fluid, 0.029 rrVO.00384 h"1 and 0.00074h"1 in plasma and O.SOlrVO.OOOOO IT1 in
uncentrifuged umbilical vein blood. During the first hours after sampling, these reaction rate constants could be
used to approximate the concentrations of M^-nitro-L-arginine methyl ester and 7V°-nitro-L-arginine at the time
of sampling.
Introduction
Nitric oxide, also known as endothelium-derived relax-
ing factor, plays an important role as a regulator of cell
functions and of communication in the body (1-3). It
is produced in the body from the terminal guanidino
nitrogen of I-arginine (3—5) and has a half life of only
a few seconds. Previous studies have shown that there
is an impotant relationship between nitric oxide and the
regulation of blood pressure during pregnancy. In patho-
logical cases, changes have been demonstrated in the
concentrations of nitrite and nitrate (6, 7). In patients
with preeclampsia, for example, the concentration of
nitrite in the blood is reduced. This reduction could be
due to the body's decreased production of nitric oxide
or an inhibition of the arginine metabolism. All ^ -sub-
stituted Z-arginines are inhibitors of nitric oxide synthe-
sis (4). These substitutes can be one or two methyl
groups or a ilitro group. These inhibitors also exhibit
changes in concentration in various body fluids. In pre-
vious studies (8, 9) two very differing half lives are
given for the degradation of A^-nitro-L-arginine methyl
ester in blood plasma: 7.5 minutes and 222 minutes.
') Lecture at the 17. Deutsche Kongreß für Perinatale Medizin,
Berlin, on December 1st 1995
This reaction represents a hydrolysis of A^-nitro-L-argi-
nine methyl ester to W°-nitro-Z,-arginine.
With the intention to determine the concentrations of
these inhibitors at a later stage in patients with patholog-
ical pregnancies, for example complicated by pre-
eclampsia or hypertension, we examined the concentra-
tions of both inhibitors, A^-nitro-l-arginine methyl ester
and A^-nitro-L-arginine, in the body fluids, particular to
and during pregnancy. We determined kinetics, such as
the reaction rate constants of these inhibitors. Conse-
quently the concentrations were measured time-depen-
dently with two different ion-chromatographic high-per-
formance liquid chromatography (HPLC) systems.
Materials and Methods
Sample collection
Amniotic fluid and venous umbilical cord blood were obtained
from the labour ward during labour or drawn from the umbilical
cord immediately following delivery. Heparinized tubes (Mono-
vette AH with canules 21G IWTW from Sarstedt, Numbrecht,
Germany) were used to collect the blood samples. The samples
were stored in a refrigerator at —20 °C and were analysed as soon
as possible.
Sample handl ing
To obtain plasma, the whole blood samples were centrifuged in a
Labofuge A centrifuge (Heraeus Christ GmbH, Osterode am Harz,
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Germany) for 10 minutes at 3000 min"1; this corresponds to a g-
forcc of about 1050.
The test tubes used for adding inhibitors to the sample were pre-
pared as follows: 50 mg albumin (as a matrix, Sigma Chemie
GmbH, Deiscnhofen or Fluka, Ncu- lm, Germany), 10 mg sodium
chloride (as a solubility promotor, Merck, Darmstadt, Germany),
about 1 mg A^-nitro-L-argininc, and approximately 2 mg A^-nilro-
L-arginine" methyl ester (both from Fluka, Neu-Ulm, Germany)
were dissolved in 10 ml distilled water, well homogenized and por-
tioned in accordance with the desired initial concentration. There-
after, the portions were freeze-dried, sealed and stored at -20 °C.
Some test tubes were only filled with either A^-nitro-L-arginine
methyl ester or A^-nitro-L-arginine instead of both substances. The
volume of amniotic fluid or blood that was added was 10 ml and
2.5 ml, respectively. After adding blood or amniotic fluid, the solu-
tion was thoroughly mixed and could immediately be prepared for
the first measurement. The samples were stored at room temper-
ature during the day and at night they were stored in a refrigerator
at a temperature of about 8 °C.
HPLC analysis and sample preparat ion
The apparatus consisted of two HPLC sets. The preparation of the
samples was earned out directly prior to measurement. The two
HPLC systems together with the data analysis were described in
detail in an earlier paper (10). One of the HPLC systems based
upon the principle of ion-exchange chromatography with a strong
cation exchanger and was first developed by Raberger and his col-
leages (8, 9, 11, 12). The second HPLC system based upon the
principle of ion-pair chromatography with a reversed phase column
and was developed by Tabrizi-Fard & Fung (13). The concentra-
tions of the two arginine derivatives in the samples were deter-
mined by the use of both separation systems in parallel studies,
where this was possible.
kB -
d.
dt
d^
dtT (
CB) = - - cB · CA
Eq. [1]
Eq. [2]
Eq. [3]
Eq. [4]
with
Αχ, £B — reaction rate constants and
CA> CA,O» CB, CB,O ~ concentration of A or B at
time t and t = 0
The coefficients could be approximated by fitting the
curve using a special programme which incorporates the
equations [1] or [2] and is applied to the measuring
points. These coefficients represent the reaction rate
constants and the initial concentration at the time t = 0.
Contrary to equation [1] no available programme suc-
ceeded in calculating realistic coefficients for equation
[2], thus the reaction rate constant kB could be estimated
only by comparison of the position of the plotted points
and the shape of the curve.
Mathemat ics and statistics
The series of measurements were evaluated with the programme
TableCurve Windows version 1.0 (curve fitting, Jandel Scientific,
San Rafael, California, USA) and with Excel version 5.0a (Micro-
soft Corporation, Incline Village, Nevada, USA).
The average value used in the statistical evaluation was the arith-
metical mean. The standard deviation was based upon the parent
population. Both of these calculations were included in Excel as
statistical functions.
Results
Figure 1 gives examples of three chromatograms, each
featuring ion-exchange and ion-pair chromatography of
the plasma sample 193 recorded at different times. The
evaluation of such series of measurements produces the
time-controlled concentration course of A/°-nitro-L-argi-
nine [ARG(NO)] and its methyl ester [L-NAME] which
is shown in figure 2 (in this case for amniotic fluid C).
The position of these plotted points is similar to the
theoretical concentration reaction of the reactants in a
uni-unimolecular two-step consecutive reaction:
which is shown in figure 3. These curves can be calcu-
lated with equations [1] and [2] which is the result of
integrating the kinetic equations [3] for substance A, and
[4] for substance B (14, 15).
ARG(NO)
L-NAME
28.5h
t = 4.5h
10mV
t = 0.5h
20 30 0 10
Retention time [minj
20 30
Fig. 1 Chromatograms (detection UV 268 nm) of umbilical vein
blood plasma 193 for different storage periods t:
a) ion-exchange chromatography - Nucleosil 100-5 SA columns
(250 mm X 4 mm -h 30 mm X 4 mm) with 50 mmol/i sodium
dihydrogen phosphate with methanol, volume fraction 0.125, pH
2.3 at 35 °C, 1 ml/min and
b) ion-pair chromatography - Eurospher 100-5 C8 column (250
mm X 4 mm) with 18.5 mmol/l heptane sulphonic acid with meth-
anol, volume fraction 0.10, pH 2.7, 1.5 ml/min.
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Fig. 2 Time dependence of the concentration of A^-nitro-L-argi-
nine methyl ester (triangles) and A^-nitro-L-arginine (squares) in
amniotic fluid C; solid - ion-exchange chromatography and hol-
low symbols - ion-pair chromatography.
Fig. 4 Plotted points from umbilical vein blood 189: plasma -
yV°-nitro-L-arginine methyl ester (triangles), A/°-nitro-L-arginine
(circles) and uncentrifuged - A^-nitro-L-arginine methyl ester
(rhombi), A^-nitro-L-argininc (squares) and the concentration
curves (constants see tabs. 1 and 2); solid symbols — ion-exchange
chromatography and hollow symbols - ion-pair chromatography.
Figure 4 shows the measuring points and the curves with
the calculated or estimated reaction rate constants (see
tabs. 1 and 2) as well as the initial concentrations from
the umbilical vein blood sample 189 and its respective
plasma.
Although A^-nitro-L-arginine methyl ester can be mea-
sured in plasma with an initial concentration of 20
μηιοΐ/ΐ even after 120 hours or 5 days, no M'-nitro-Z,-
arginine methyl ester was detected in uncentrifuged
blood after 6 hours in spite of an initial concentration of
about 30 μιηοΐ/ΐ. However, A/°-nitro-L-arginine could
still be found in amniotic fluid (fig. 2) with the same
initial concentration even after 240 hours or 10 days. On
the other hand, MMiitro-L-arginine having approxi-
mately the same initial concentration, could still be de-
tected weeks later.
Hence the stoichiometric equation of the two-step con-
secutive reaction can be written as follows:
200 300
Time [h]
500
Fig. 3 Calculated concentration curves, related to the initial con-
centration, with variation of the reaction rate constants for a con-
secutive reaction with
(a) equation [1]: &A = 0^02, and 0.05 h"1,
(b) equation [2]: kA = 0.02 h"1, and
A'B = 0.0100, 0.0075, 0.0050 hr1, and
(c) equation [2J: *A = 0.02, 0.05 h~ l , and kB = 0.0025 h"1
I-NAME L-NAME . ARG(NO) ^ARG(NO). 999
By means of amino acid analysis with o-phthaldialde-
hyde pre-column derivatization (10) it was not possible
to determine to which amino acid A^-nitro-L-arginine
decomposes. Considering the concentrations of both ar-
ginine derivatives that were used, a clear increase in the
concentration of one of the amino acids should have
been traceable. Thus, the question arises whether the de-
gradation product of nitro arginine is an amino acid at
all.
Tables 1 to 3 demonstrate the calculated or estimated
reaction rate constants for all examined samples. In
some samples only TV^-nitro-L-arginine was added.
Thus, equation [1] (in this case being valid for W°-nitro-
L-arginine) could be used not only to estimate but also
to calculate the constant.
Discussion
HPLC measurements
In both separation systems used, approximately the con-
centrations were measured for both substances. Since
the peak of A^-nitro-l-arginine methyl ester stands veiy
isolated in the chromatogram, inaccuracies may have
arisen during sample preparation. In spite of using the
same pipette, there were small differences in the vol-
umes used for deproteinizing. In the case of A/°-nitro-L-
arginine errors occurred due to the peak not being suffi-
ciently separated from the peaks of other eluting sub-
stances immediately before or after it (see fig. 1). As
illustrated in figure 2, the points plotted for JV°-nitro-L-
arginine produce a scattered cloud in contrast to those
of A^-nitro-L-arginine methyl ester. The separation of
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A^-nitro-L-arginine from the other "disturbing" sub-
stances also depends on their concentrations. Further-
more, the unwanted but unavoidable inconsistancies of
some Chromatographie conditions are also present in
these measurements, such als fluctuations in the measur-
ing temperature or in the composition of the eluents,
sample cannot be assumed to have been stored at a con-
stant temperature in normal daily clinical routine.
Tab. 2 Results for the reaction rate constants in uncentrifiiged
umbilical vein blood.
Kine t ics
A further reason for the appearance of this scattered
cloud is attributable to the fact that the samples were
purposely not stored at a constant temperature (at night
and over the weekend in the refrigerator at 8 °C but at
the time of measuring at room temperature between 20
and 30 °C).
termination
This, in fact, constitutes an error in the de-
of kinetic data.
ately done here in order to
"controlled"
valid for a
by temperature
However, this was deliber-
obtain values which are not
and hence values which are
particular temperature range only, since a
Tab. 1 Results for the reaction
blood plasma.
Plasma no.
3
5
7
11
13
22
23
95£*j
29
30
34
35
36
42
46
47
48
49
50
53
55
56
57
59
61
181
189
193
214
216
221
250
251
AL-NAME [h
0.033
0.048
0.032
0.027
0.040
0.021
0.021
0 035
0.029
0.026
0 017\J.\J I I
0.048
0.039
0.018
0.036
0.036
0.066
n.a.
0.020
0.034
0.012
0.016
0.015
0.014
0.014
0.025
0.025
0.033
0.017
n.a.1)
n.a.1)
0.030
0.046
Average 0.029
Standard deviation 0.0 1 2
Number 30
rate constants in umbilical vein
~
]] ^ARG(NO) Ρ1"1]
Group 1 Group 2
n.a.1)
n.a.1)
0.00750
0.00100
0.00250
0.00200
0.00250
Π ΠΠ7^Π
0.00750
0.00750
0 009 SO\J.\J\J Z, J\J
0.00150
n.a.1)
0.00200
0.00250
0.00250
0.00200
0.00340
0.00075
0.00100
0.00125
0.00075
0.00100
0.00075
0.00075
0.00075
0.00075
0.00025
0.00025
0.00020
0.00020
0.00400
0.00040
0.00384 0.00074
0.00217 0.00036
14 16
108
109
117
118
122
123
130-a2)
130-b2)
140
144
145
146
174
176
178
181
182
183
189
204
212
216
Average
Standard deviation
Number
!) n.a. = not added
n.a.1)
n.a.
n.a.
n.a.
n. a. ' r
n.a.
0.80
n.a.1)
0.80
0.80
0.80
0.80
0.80
0.80
0.80
0.80
0.80
0.80
0.80
0.72
0.93
n.a.1)
0.80
0.04
14
0.00010
0.00010
0.00075
0.00050
0.00050
0.00025
0.00050
0.00100
0.00075
0.00075
0.00075
0.00075
0.00075
0.00075
0.00075
0.00075
0.00075
0.00075
0.00075
0.00050
0.00050
0.00020
0.00060
0.00024
22
2) different measurement series of one sample
Tab. 3 Results for the
Amniotic
fluid no.
A
Β
C
D
E
F
G-a2)
G-b2)
G-c2)
H
I
J
K
L
M
N
0-a2)
0-b2)
P
Q
R
Average
Standard deviation
Number
reaction rate constants
*Δ~ΝΑΜΕ [h"1]
0.023
0.010
0.0 11
0.034
0.035
0.035
n.a.1)
n. a.1)
n.a.1)
n. a.1)
n.a.1)
n. a.1)
0.060
0.034
0.034
n. a.1)
0.041
n. a.1)
0.036
0.042
0.019
0.032
0.013
13
in amniotic fluid.
^ARG(NO) [n~ ]
0.000700
0.000500
0.000500
0.000500
0.000300
0.000650
0.000625
0.000625
0.000625
0.000625
0.000625
0.000625
0.000250
0.000250
0.000250
0.000500
0.000250
0.000250
n.a.1)
0.000250
0.000500
0.000470
0.000166
20Λ·\1
n.a. = not added 2) different measurement series of sample
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Nevertheless, the similarity between the position of the
points plotted and the theoretic curves of concentrations
is quite obvious when comparing figure 1 with figure 2.
In figure 2 there is not only a theoretical pair of curves
to be seen but simultaneously also changes in the shape
of the curves due to the variation of a reaction rate con-
stant. If sufficient measurements are made, the reaction
rate constants for A^-nitro-L-arginine methyl ester can
be calculated in equation [1] without any problems. No
programme succeeded in calculating the constants for
A^-nitro-L-arginine in equation [2], since these are
probably present in the equation too often. Hence, these
constants could only be obtained by a visual comparison
48 96 144 192 240 288 336 384 432 480
Time [h]
240 480 720 960 1200 1440 1680 1920
Time [h]
360 480
Time [h]
600 720 840
Fig. 5 Plotted points of all amniotic fluid Samples: a) A/°-nitro-
L-arginine methyl ester, b) /v^-nitro-L-arginine where A^-nitro-I-
arginine methylester was added, and c) A^-nitro-I-arginine only -
sample no. G-a to J, N, and O-b; solid ion-exchange chromatogra-
phy and hollow symbols - ion-pair chromatography; and the con-
centration curves calculated with the mean value (solid line), mean
value minus standard deviation (dotted line), and mean value plus
standard deviation (dashed line) of the reaction rate constants (for
the numerical values see tab. 3).
of the position of the measured values and a single curve
which includes the values calculated for A^-nitro-L-ar-
ginine methyl ester and then estimated from these given
values. Thus, a good agreement could be achieved and
the reaction rate constants could be determined (see fig.
4). The measurement of A/°-nitro-L-arginine on its own
without A/°-nitro-L-arginine methyl ester confirmed this
agreement. In this case the kinetic equation is valid, in
which the constants can be calculated, as shown in equa-
tion [1]. Several constants for A/°-nitro-L-arginine
methyl ester had to be estimated by comparison as well,
particularly those for the uncentrifuged blood, as not
enough data could be obtained.
The values in the tables, whether calculated or estimated,
do not vary much from each other except in the case of
the plasma samples (tab. 1). Nevertheless, differences
can be recognized which certainly arise due to the sam-
ples having been handled in different ways. However,
each sample (whether amniotic fluid, plasma or un-
centrifuged blood) is an individual substance in inself.
Table 1 demonstrates that the constants of A^-nitro-Z,-
arginine in plasma can be divided into two groups. A
measurement with umbilical artery blood, the constant
of which would be equal to those of group 1, gives a
possible explanation. Perhaps only the blood from group
2 is venous blood and that of group 1 is in fact arterial
blood (contrary to the declaration)? This is only one pos-
sible explanation. It may also be possible that the sam-
ples of one group contain substances that act in plasma
either as an accelerator or certain catalyst (group 1) or
as a retardant or species of inhibitor (group 2).
In figure 5 all points for A/°-nitro-L-arginine methyl es-
ter and A^-nitro-L-arginine as well as those for A/°-ni-
tro-L-arginine alone have been taken from all the amni-
otic fluid samples listed. The continuous curves have
been calculated using the average values of the reaction
rate constants for amniotic fluid and the assumed
"average" initial concentrations. The fact that the plotted
points are scattered around the curve is due to the vary-
ing concentrations among the individual samples. How-
ever, the shapes of these curves show very accurately
the concentration to be time dependent in individual
cases. Part C of figure 5 shows two extra curves calcu-
lated with the mean value plus or minus standard devia-
tion, respectively (dashed line or dotted line) in addition
to the curve calculated using the average of the con-
stants. During the first hours after addition of the argi-
nine derivative, there are only small differences visible
between the three curves. Thus, the mean can be used
to calculate the concentrations, in spite of the large stan-
dard deviations of up to approximately 60% of the
average.
ln(2)
'l/2,i = -7- E<l· t5]
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In order to compare our results with those in the litera-
ture (8, 9), the half lives were calculated using the mean
of the reaction rate constants k\ according to equation
[5]. In uncentrifuged blood the half lives for A^-nitro-
L-arginine methyl ester were 51.75 min and 180 h
(group 1) or 39 d (group 2), "for A^-nitro-L-arginine
alone in plasma 24 h and 13d and in amniotic fluid 22 h
and 61.5 d. The half lives given for human body fluids
are longer than those in blood samples from rabbits in
vivo 7.5 min (8) and in plasma from canine blood in
vitro 222 min (9).
Conclusion
The mean values determined for the reaction rate con-
stants in the degradation of 7V°-nitro-L-arginine methyl
ester and its A/°-niuO-L-arginine are confirmed to be
suitable for calculating the concentrations of one or both
substances at the time of sampling in the first approxi-
mation using equations [6] and [7], derived from [1] and
[2]. Equation [7] is only required for calculating N°-
nitro-L-arginine if both substances are present in a sam-
ple.
<?i,o = c\' eAv' with i = A or B Eq. [6]
- kA
Eq.[7]
Hereby the time interval between sampling and analysis
must be as short as possible, not exceeding a few hours.
The best example would be the uncentrifuged blood if
the concentration of the A^-nitro-L-arginine methyl es-
ter (if present) is to be determined. Some half life values
do point to this. Also having some determinations of the
concentration made at short intervals, would render the
calculations even more reliable. In this case the indivi-
dual differences are not clearly distinguishable.
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